1) Only Capomulin and Ramincane correlated with tumor volume reduction, whereas all other drugs in the experiment did not.
2) Capomulin and Ramincane also had higher survival rates compared to the other drugs.
3) Finally, Capomulin and Ramincane had lower metastatic response >>> it's clear that these 2 are the winners. Further analysis required to further understand how these 2 drugs distinguish from each other.